Body Handbook Catalogue Profile Ranking
Gut BODY HANDBOOK
Gut ยท ยง89
Long-Term PPI Use
Omeprazole and its cousins (Prilosec, Nexium, Prevacid) are among the best heartburn drugs ever made, and among the most over-used. They were built for eight-week courses; tens of millions of people are on year five. The catch nobody's told: stopping the drug causes heartburn even in people who never had it, so most refill and stay on for decades. The real cost of those decades is quiet. If you started one for indigestion and never came off, this is worth reopening.
Avoid ยท As-needed Evidence Moderate Chapter Gut

The drug works too well to quit casually. A proton pump inhibitor jams the pump your stomach uses to make acid, dropping acid output eighty to ninety-five percent. Suppress acid for years and your body compensates: the acid-making cells multiply. When the drug comes off, an enlarged acid factory fires up on a hyper-reactive stomach. That's the rebound, and it's the whole trap.

Stomach acid has a day job. It pulls B12 off your food, dissolves calcium and iron, and sterilises the bacteria you swallow. Knock it out for a decade and each job degrades. The long-term signals are large and consistent: half again the rate of chronic kidney disease 1, roughly double the risk of kidney failure versus the older heartburn pill 2, and forty-four percent more hip fractures in long-term users 3.

Missing acid also lets infections through: nearly double the rate of C. difficile gut infection 4 and about a quarter more pneumonia 5. B12 deficiency runs two-thirds more common after two years 6; magnesium gets its own FDA warning 7. None of this is dramatic in any single year. That's exactly why it compounds unnoticed.

Don't quit cold. Taper, and expect the drug to fight back. If you've been on a PPI more than eight weeks, the question for your doctor is whether you still have a reason to be. The deprescribing plan comes from current AGA guidance 8.

Weeks one to eight are the hard part. The rebound burning peaks in the first two weeks and is mostly gone by week eight; keep antacids at the bedside. Months three to six bring the quiet wins: magnesium recovers and cramps ease, sleep steadies, and any B12 fatigue lifts. The rest is counterfactual: kidney function still normal at sixty-five, the hip that didn't break at seventy-two. Most of the benefit is simply not adding more years on the drug.

The fine print โ€” when to skip it, and what people get wrong

"The burning came back, so I need the drug." Usually it's withdrawal: 44% of healthy volunteers with no reflux got heartburn after stopping an eight-week course 9 10. It clears in four to eight weeks.

Stay on if you have a real indication: Barrett's esophagus, unhealed severe erosive esophagitis, recent upper-GI bleed on blood thinners, high-dose NSAIDs with a prior ulcer, or Zollinger-Ellison. On clopidogrel (Plavix), ask for pantoprazole or rabeprazole, not omeprazole.

Counter-evidence: a three-year randomised trial of 17,598 patients saw harm only for gut infection 11. But the worrying signals sit at five to fifteen years, which three clean years can't rule out.

References
  1. 1Lazarus B, Chen Y, Wilson FP, et al. (2016). Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease. JAMA Internal Medicine. link
  2. 2Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z (2017). Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury. Kidney International. link
  3. 3Yang YX, Lewis JD, Epstein S, Metz DC (2006). Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. link
  4. 4Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN (2012). Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. American Journal of Gastroenterology. link
  5. 5Eom CS, Jeon CY, Lim JW, Cho EG, Park SM, Lee KS (2011). Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis. Canadian Medical Association Journal. link
  6. 6Lam JR, Schneider JL, Zhao W, Corley DA (2013). Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. link
  7. 7FDA (2011). FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs). link
  8. 8Targownik LE, Fisher DA, Saini SD (2022). AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review. Gastroenterology. link
  9. 9Reimer C, Sondergaard B, Hilsted L, Bytzer P (2009). Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology. link
  10. 10Niklasson A, Lindstrom L, Simren M, Lindberg G, Bjornsson E (2010). Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial. American Journal of Gastroenterology. link
  11. 11Moayyedi P, Eikelboom JW, Bosch J, et al. (2019). Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin. Gastroenterology. link
ยท
89